Dr Patrick Vallance, currently the President of Research and Development at GlaxoSmithKline, has been confirmed as the Government’s new chief scientific officer. He takes over from Professor Chris Whitty who currently holds the role on an acting basis.
Sir Jeremy Heywood, the Cabinet Secretary, said in a statement:
“This is an excellent appointment for the Civil Service, in an important area of government business. Patrick Vallance has already advised the government on several occasions in his capacity as a Member of the UK Ministerial Industry Strategy Group, so he is well placed to offer the best scientific advice available to the Prime Minister and other members of the Cabinet. I am also looking forward to the contribution Patrick will make in leading the science community across government, building on the great work of Sir Mark Walport, his predecessor.
I would also like to take this opportunity to thank Sir Mark for the invaluable contribution he has made to policy development and strengthening Whitehall’s already world-class science capability”.
Vallance said about his new role:
“It is a great honour to join the Civil Service as the Government Chief Scientific Adviser. Science, engineering and technology have a vital role to play at the heart of policy making and are critical to economic growth and prosperity in the UK as well as to addressing many of the greatest challenges of our time, such as environmental change and keeping our citizens healthy and secure.
I look forward to working with colleagues to ensure the government has the best possible advice, from the best experts, based on the strongest evidence, to inform the widest range of policy decisions”.